Skip to main content

Table 5 Meta-regression results

From: The Role of Aerobic Training Variables Progression on Glycemic Control of Patients with Type 2 Diabetes: a Systematic Review with Meta-analysis

Moderator

Number of study estimates

Β

95% CI

p value

R 2

Progressive aerobic training

 Mean age

14

0.045

− 0.074; 0.166

0.457

0.00

 Percentage of women in the sample

10

− 0.007

− 0.056; 0.041

0.765

0.00

 Body mass index

13

− 0.737

− 1.346; − 0.128

0.017

0.20

 Diagnosis duration

11

0.076

−0.069; 0.223

0.303

0.00

 Baseline HbA1c

10

0.009

−1.508; 1.318

0.895

0.00

 Glucose lowering drug users

5

− 0.080

− 0.113; − 0.046

< 0.001

1.00

 Follow-up duration

14

− 0.088

− 0.147; − 0.029

0.003

0.37

 Weekly frequency

14

− 0.426

− 1.677; 0.825

0.504

0.00

 Session duration

13

− 0.005

− 0.055; 0.043

0.820

0.00

 Weekly duration

13

0.001

− 0.016; 0.017

0.960

0.00

Non-progressive aerobic training

 Mean age

12

0.001

− 0.001; 0.002

0.442

0.00

 Percentage of women in the sample

10

0.003

− 0.013; 0.021

0.662

0.00

 Body mass índex

12

0.096

− 0.039; 0.232

0.163

0.00

 Diagnosis duration

10

− 0.015

− 0.449; 0.417

0.942

0.00

 Baseline HbA1c

12

− 0.229

− 0.898; 0.440

0.502

0.06

 Glucose lowering drug users

8

− 0.027

− 0.099; 0.045

0.462

0.00

 Follow-up duration

13

0.005

− 0.046; 0.056

0.846

0.00

 Session duration

13

− 0.026

− 0.058; 0.007

0.128

0.09

 Weekly frequency

13

− 0.536

− 0.904; − 0.168

0.004

0.38

 Weekly duration

13

− 0.005

− 0.010; − 0.001

0.020

0.27

  1. Numbers in italic indicate statistical significance (p < 0.05)